T-cells and precision medicine for allergic bronchopulmonary aspergillosis

The pathogenesis of allergic bronchopulmonary aspergillosis (ABPA) remains poorly understood, despite its widely accepted recognition as a distinct endotype of severe asthmatic disease [1]. Unravelling the central role of T-cell subpopulations in ABPA can lead to personalised targeting of pathogenetic pathways